PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 114 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $241,000 | -39.9% | 80,997 | -9.3% | 0.00% | – |
| Q4 2021 | $401,000 | -8.9% | 89,338 | -1.4% | 0.00% | – |
| Q3 2021 | $440,000 | -26.2% | 90,606 | +3.6% | 0.00% | – |
| Q2 2021 | $596,000 | -4.5% | 87,443 | -1.1% | 0.00% | – |
| Q1 2021 | $624,000 | +8.9% | 88,405 | -3.4% | 0.00% | – |
| Q4 2020 | $573,000 | +13.5% | 91,553 | -2.0% | 0.00% | – |
| Q3 2020 | $505,000 | -1.2% | 93,376 | -4.7% | 0.00% | – |
| Q2 2020 | $511,000 | +24.9% | 97,971 | -24.6% | 0.00% | – |
| Q1 2020 | $409,000 | -29.0% | 129,902 | -9.2% | 0.00% | – |
| Q4 2019 | $576,000 | -45.2% | 142,996 | -41.3% | 0.00% | -100.0% |
| Q3 2019 | $1,052,000 | +59.4% | 243,623 | +47.3% | 0.00% | 0.0% |
| Q2 2019 | $660,000 | +72.8% | 165,448 | +131.9% | 0.00% | – |
| Q1 2019 | $382,000 | +77.7% | 71,352 | +70.3% | 0.00% | – |
| Q4 2018 | $215,000 | +15.0% | 41,896 | +117.1% | 0.00% | – |
| Q3 2018 | $187,000 | +23.8% | 19,295 | +30.2% | 0.00% | – |
| Q2 2018 | $151,000 | -44.3% | 14,824 | -28.8% | 0.00% | – |
| Q1 2018 | $271,000 | -76.2% | 20,831 | -67.2% | 0.00% | -100.0% |
| Q4 2017 | $1,138,000 | -15.4% | 63,565 | +18.6% | 0.00% | 0.0% |
| Q3 2017 | $1,345,000 | -23.0% | 53,577 | -26.1% | 0.00% | -50.0% |
| Q2 2017 | $1,747,000 | – | 72,493 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |